IV Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

IV Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The IV bags market is expected to record a CAGR of 5.3% over the forecast period.

COVID-19 had a notable impact on the overall healthcare industry. As per the report published in Omnia Health under the title “COVID-19 response: Maintaining effective and safe IV infusion therapy for isolated patients”, during the pandemic, a large pool of patients was isolated and changing their IV bags frequently became a difficult task for the nurses and caretakers. Some clinics started using long extension lines that allowed the patient's pumps to stay outside the isolation room to cut down on the time nurses spend changing the IV bags and intermittently administering IV medications within rooms of patients with COVID-19. Furthermore, as per the article published in 2022 under the title "Vitamin IV & Long COVID", in long-term COVID-19 patients, high-dose IV vitamin C therapy considerably improves exhaustion and fatigue-related symptoms such as sleep problems and loss of focus. Since intravenous infusion speeds up the delivery of Vitamin C to the patient's body, more people are accepting IV infusion therapy, which is fueling the growth of the IV bag market. Additionally, as per the 2020 update from the United States Food and Drug Administration, the authority had issued an emergency use authorization (EUA) for casirivimab and imdevimab which were instructed to be administered together as an intravenous infusion for the treatment of mild to moderate COVID-19 in adults and pediatric patients. Therefore, due to the adoption of IV infusions for COVID-19 treatments, the use of IV bags was anticipated to surge during the pandemic. As per the facts mentioned above, COVID-19 significantly impacted the IV bags market.

The major factor attributing to the growth of the market is the increase in the prevalence of diseases, such as gastrointestinal diseases, neurological diseases, and cancer where IV fluids are given to the patients. According to the World Health Organization, diarrhoeal disease is the second leading cause of death in children under five years old. For instance, as per the “Pneumonia & Diarrhea Progress Report 2020”, in India 233,240 children under the age of 5 died out of pneumonia or diarrhea in 2020. To control the issues related to diarrhea, proper and immediate treatment is necessary. IV bag fluids are used to prevent dehydration, maintain blood pressure, or give patients medicines or nutrients if they are not able to eat, which is best for quick stabilization once the minerals from the body are lost due to diarrhea.

Furthermore, the increasing geriatric population is one of the major driving factors in the IV bag market. Older people mostly needed additional requirement of nutrients and minerals after surgery. This can be quickly established by the IV infusion. For instance, as per the article published in 2022 under the title "The impact of intravenous iron supplementation in elderly patients undergoing major surgery", intravenous iron supplementation increases Hb level and thereby reduces blood transfusion rate in elderly surgical patients with iron deficiency anemia. Hence, IV bags are widely used for essential IV infusion practices, which boosts the market growth over the forecast period. Moreover, a study published in 2021 under the title "Vitamin C Administration by Intravenous Infusion Increases Tumor Ascorbate Content in Patients With Colon Cancer: A Clinical Intervention Study", stated that there were potential advantages to the targeted use of vitamin C infusions, rather than oral supplementation, in patients with solid tumors. Thus the utilization of vitamin C infusions in cancer patients leads to the adoption of IV bags which is likely to boost the market growth.

As per the aforementioned factors, the IV bag market is anticipated to grow over the forecast period. However, the risk of leaching chemicals from plastic IV bags is the major factor restraining the market.

Key Market TrendsPolypropylene Segment is Expected to Dominate the IV Bags Market

The increasing usage of polypropylene for manufacturing IV bags can be attributed to the advantages of the material over the other existing ones. PVC usage has declined due to the risk of the release of toxins in the packaged solution. The advantages of polypropylene are that it is relatively inexpensive, possesses high flexural strength because of its semi-crystalline nature, resistant to moisture, and possesses good fatigue resistance.

The presence of competitors, mergers, acquisitions, and product launches boosts market growth. For instance, in June 2022, Gufic Biosciences collaborated with its French counterpart to manufacture this new technology indigenously in India. The dual-chamber bags launched by Gufic Biosciences were 2-Chamber IV Bags, made up of polypropylene (DEHP free) with a peelable aluminum foil allowing the storage of unstable drugs which need a reconstitution just before the administration to the patient.

Apart from the advantages of the material, the increasing gastrointestinal and neurological diseases and increasing prevalence of cancer are a few major factors boosting the segment growth. For instance, as per the report from American Cancer Society, by 2040, the global burden of cancer is expected to grow to 27.5 million new cancer cases. Furthermore, the increasing geriatric population globally is enhancing the segment expansion. For instance, as per World Population of Ageing, the number of older persons is projected to double to 1.5 billion by 2050.

Hence as per the factors mentioned above, polypropylene segment is expected to witness a growth over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to the factors, such as the presence of key players, the high prevalence of diseases like cancer, and gastrointestinal diseases in the region, and established healthcare infrastructure are some of the key factors accountable for its large share in the market. For instance, as per the report from Global Cancer Observatory, 2.28 million people were affected by cancer in 2020, which is expected to project the count to 3.12 million by 2040 in the United States.

Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region, the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market. The presence of competitors, mergers, acquisitions and new product launches fuels the market growth. For instance, in February 2022, B. Braun Medical, a German infusion therapy company, received the United States Food and Drug Administration’s approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida. The facility, which is part of the company’s agreement to spend USD 1 billion on its U.S. manufacturing and supply chain to address shortages of IV fluids and is anticipated to produce 0.9% sodium chloride for injection.

Hence as per the factors mentioned above, North America is likely to grow over the forecast period for the studied market.

Competitive Landscape

The IV Bags market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Baxter International Inc., Technoflex, Sippex IV bag, POLYCINE GmbH, ICU Medical Inc., and B. Braun Medical Inc., among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.